Bidirectional control of vesicular GABA release, LTP, and amotivation by GluN2D-selective allosteric modulators and ketamine

Viktor J. Oláh, Isabelle F. Witteveen, Tue G. Banke, Alexa M. Leahy, Ryan Keable, Riley E. Perszyk, Cara T. Khayat, TrangKimberly T. Nguyen, Brianna J. Bixler, Frances G. Ghinger, Detlef Vullhorst, Yeeun Yook, Scott J. Myers, Elijah Z. Ullman, Jing Zhang, Hao Xing, John F. Traynelis, Eva S. Diaz, Sukhan Kim, Sophia Boraschi, Nicholas S. Akins, Ken H. Liu, Alet van der Westhuyzen, Yanli Yang, Chad R. Camp, Andres Buonanno, Randy A. Hall, James Q. Zheng, Dennis C. Liotta, Matthew J. Kennedy, Katherine W. Roche, Shannon L. Gourley, Hongjie Yuan, Matthew J.M. Rowan, Stephen F. Traynelis · 2026

Read Bidirectional control of vesicular GABA release, LTP, and amotivation by GluN2D-selective allosteric modulators and ketamine by Viktor J. Oláh, Isabelle F. Witteveen, Tue G. Banke, Alexa M. Leahy, Ryan Keable, Riley E. Perszyk, Cara T. Khayat, TrangKimberly T. Nguyen, Brianna J. Bixler, Frances G. Ghinger, Detlef Vullhorst, Yeeun Yook, Scott J. Myers, Elijah Z. Ullman, Jing Zhang, Hao Xing, John F. Traynelis, Eva S. Diaz, Sukhan Kim, Sophia Boraschi, Nicholas S. Akins, Ken H. Liu, Alet van der Westhuyzen, Yanli Yang, Chad R. Camp, Andres Buonanno, Randy A. Hall, James Q. Zheng, Dennis C. Liotta, Matthew J. Kennedy, Katherine W. Roche, Shannon L. Gourley, Hongjie Yuan, Matthew J.M. Rowan, Stephen F. Traynelis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13581442.txt.

Description

Viktor J Oláh and a large team of co-authors locate a little studied receptor at the release sites of calming brain cells, in a 2026 study. The receptor variant, built with a part called GluN2D, sits on the sending tips of a key interneuron type in the hippocampus. Its tail carries the address label that parks it there. Background glutamate levels switch it on, and it then dials the release of the calming signal GABA up or down.

Drugs that tune this receptor family, plus low dose ketamine, lost their grip on GABA release in mice missing the part in those cells. One selective blocker copied ketamine's lasting gains: stronger memory wiring and restored reward drive in a depression model, without ketamine's side effects. The authors nominate the receptor as a drug target.

Catalog record

CREATORViktor J. Oláh, Isabelle F. Witteveen, Tue G. Banke, Alexa M. Leahy, Ryan Keable, Riley E. Perszyk, Cara T. Khayat, TrangKimberly T. Nguyen, Brianna J. Bixler, Frances G. Ghinger, Detlef Vullhorst, Yeeun Yook, Scott J. Myers, Elijah Z. Ullman, Jing Zhang, Hao Xing, John F. Traynelis, Eva S. Diaz, Sukhan Kim, Sophia Boraschi, Nicholas S. Akins, Ken H. Liu, Alet van der Westhuyzen, Yanli Yang, Chad R. Camp, Andres Buonanno, Randy A. Hall, James Q. Zheng, Dennis C. Liotta, Matthew J. Kennedy, Katherine W. Roche, Shannon L. Gourley, Hongjie Yuan, Matthew J.M. Rowan, Stephen F. Traynelis
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE79 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13581442

Browse the full library · About the Tower of Babel